SCHEMBL6027201

SCHEMBL6027201

O=Cc1c(OCCCCC(=O)O)ccc(Cl)c1O

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.43
PPARA Q07869 4/20 0.41
PPARG P37231 2/20 0.40
ALB P02768 1/20 0.39
CYSLTR2 Q9NS75 3/20 0.39
CYSLTR1 Q9Y271 3/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.39
CNR2 P34972 1/20 0.39
TSHR P16473 1/20 0.38
MAPT P10636 1/20 0.38
FFAR1 O14842 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6026214 0.83 PPARA (0.53) RAB9APPARAPPARGCYSLTR2CYSLTR1
SCHEMBL11146006 0.83 CNR2 (0.44) PPARACYSLTR2CYSLTR1CNR2
SCHEMBL11008385 0.82 RAB9A (0.40) RAB9APPARAPPARGALBPTGDR2
SCHEMBL6026812 0.82 CYSLTR2 (0.46) PPARACYSLTR2CYSLTR1TSHRTDP1
SCHEMBL7316795 0.81 RAB9A (0.40) RAB9APPARAPPARGCYSLTR2CYSLTR1
SCHEMBL7320935 0.80 RAB9A (0.39) RAB9APPARAPPARGALBCYSLTR2
Hydrochloric Acid SCHEMBL7311714 0.80 RAB9A (0.39) RAB9APPARAPPARGCYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL7310519 0.79 RAB9A (0.38) RAB9APPARAPPARGALBCYSLTR2
SCHEMBL6026423 0.78 PYGL (0.41) RAB9APPARAPPARGALBCYSLTR2
SCHEMBL2554389 0.77 RAB9A (0.51) RAB9APPARAPPARGALBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US claimed
CN-1326358-A Method of DNA vaccination GLAXO GROUP LTD (GB) 2001-12-12 CN claimed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP claimed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO claimed
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US disclosed
CN-1326358-A Method of DNA vaccination GLAXO GROUP LTD (GB) 2001-12-12 CN disclosed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP disclosed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO disclosed
EP-0614357-A1 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-09-14 EP disclosed
WO-1994007479-A2 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-04-14 WO disclosed
EP-0054924-B1 PHARMACEUTICAL COMPOUNDS, THEIR PREPARATION AND USE THE WELLCOME FOUNDATION LIMITED (GB) 1986-08-06 EP disclosed
US-4535183-A PALLIATION OF SICKLE CELL ANEMIA, RESPIRATORY DISORDERS, HYPOXIA, RADIOSENSITIZATION OF TUMORS BURROUGHS WELLCOME CO. (US) 1985-08-13 US disclosed
EP-0054924-A2 Pharmaceutical compounds, their preparation and use THE WELLCOME FOUNDATION LIMITED (GB) 1982-06-30 EP disclosed